ADIPOQ and lung cancer: This result contradicts with previous studies, which have shown that adiponectin levels increased significantly in cachectic patients with gastric and gastrointestinal cancers [16, 19] or remained unchanged in cachectic and noncachectic patients with breast, colorectal, and lung cancers [9, 31].